Supplementary Table. Sensitivity Analysis of Estimated Nirsevimab Effectiveness Against Medically Attended Acute Respiratory Illness and Hospitalization From Respiratory Syncytial Virus, Overall and by Child’s Respiratory Syncytial Virus Season — Yukon-Kuskokwim Region, Alaska, October 23, 2023–June 30, 2024

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Supplementary Table. Sensitivity Analysis of Estimated Nirsevimab Effectiveness Against Medically Attended Acute Respiratory Illness and Hospitalization From Respiratory Syncytial Virus, Overall and by Child’s Respiratory Syncytial Virus Season — Yukon-Kuskokwim Region, Alaska, October 23, 2023–June 30, 2024

11/14/2024
By Centers for Disease Control and Prevention (U.S.).
Source: MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 45
Series: Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

English

Details You May Also Like

Details:

Alternative Title:

Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024: Supplementary Table. Sensitivity Analysis of Estimated Nirsevimab Effectiveness Against Medically Attended Acute Respiratory Illness and Hospitalization From Respiratory Syncytial Virus, Overall and by Child’s Respiratory Syncytial Virus Season — Yukon-Kuskokwim Region, Alaska, October 23, 2023–June 30, 2024
Corporate Authors:

Centers for Disease Control and Prevention (U.S.).
Description:

Supplementary Table. Morbidity and Mortality Weekly Report, Vol. 73, No. 45, November 14, 2024
Subjects:

[+]

Disease Control Disease Notification Public Health Public Health Surveillance Respiratory Syncytial Virus Infections / Prevention & Control
Source:

MMWR: Morbidity and Mortality Weekly Report 2024; v. 73, no. 45
Series:

Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
ISSN:

0149-2195 (print);1545-861X (digital);
Document Type:

Journal article
Genre:

Tables ; Statistics

Tables ; Statistics Less -
Place as Subject:

United States
Pages in Document:

1 pdf page
Volume:

73
Issue:

45
Collection(s):

Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha-512:ef708dc742aa1e8cb981c845a81b9b701e4b74af9b9ff9b57d5b260b5763e4b949b49da4ecb88f950b0500b9f05ebc4d27cf7b3db75c2b804d7e9f8e88553485
Download URL:

https://stacks.cdc.gov/view/cdc/168888/cdc_168888_DS1.pdf
File Type:

[PDF-140.11 KB]